Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?

Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Valeant Pharmaceuticals hired Louis Yu as chief quality officer, which is a new position. Previously, he worked at AMRI, a contract research and manufacturing company, as senior vice president, global quality and compliance. Before that he spent a decade at Perrigo, where he most recently was executive vice president, global quality and compliance.

advertisement

Astellas hired Dr. Steven Benner as senior vice president and therapeutic area head for oncology;

Astellas hired Anne Keating as vice president of clinical science for oncology;

advertisement

Nanobiotix hired Dr. Mihail Obrocea as head of US clinical development;

Nanobiotix hired Noel Kurdi as director of investor relations;

Deciphera Pharmaceuticals hired Christopher Morl as chief business officer;

Sellas Life Sciences hired William Pollett as chief financial officer;

Sellas Life Sciences promoted Martin Baum to chief operating officer;

Sellas Life Sciences hired Dr. Nicholas Sarlis as senior vice president, chief medical officer;

Prothena Corporation hired Gene Kinney as chief executive officer and president;

Lion Biotechnologies hired Gregory Schiffman as chief financial officer;

Moderna Therapeutics hired Annie Seibold Drapeau as chief human resources officer;

Deciphera Pharmaceuticals hired Christopher Morl as chief business officer;

Catabasis Pharmaceuticals promoted Andrew Nichols to chief scientific officer;

Catabasis Pharmaceuticals promoted Angelika Fretzen to senior vice president, product development;

Advaxis hired Christopher Duke as senior vice president and chief operating officer;

INC Research Holdings promoted Michael Gibertin to chief operating officer;

INC Research Holdings promoted Tara Fitzgerald to president, clinical development services;

Merrimack Pharmaceuticals says Robert Mulroy resigned as chief executive officer;

Merrimack Pharmaceuticals named Gary Crocker as interim chief executive officer;

Taro Pharmaceuticals hired Mariano Balaguer as vice president and chief financial officer;

Editas Medicine hired Dr. Gerald Cox as chief medical officer;

Editas Medicine hired Kenneth LeClair as vice president, technical development and manufacturing;

Editas Medicine hired Semiramis Trotto as vice president, human resources;

Mirati Therapeutics hired Chris LeMasters as executive vice president and chief business officer;

Noven Pharmaceuticals hired Ralph Lipp as vice president and chief scientific officer;

Marathon Pharmaceuticals hired Dr. Rick Munschauer as vice president and chief medical officer.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy